Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by Locknstocknon Mar 07, 2020 11:56am
209 Views
Post# 30779007

Bashers say what you want, but im all in.

Bashers say what you want, but im all in.
If I look back at all the canopy Bashers before it made its huge run in November 2017, they all said the same negative BS. "Be Careful, Dont get caught".......I say go 4 it. How could you not want to invest? Bruce Linton (On board of Directors) and Mr.Wonderful are not stupid, and have done there homework. Dont forget, Kevin O'Leary didnt invest a cent into the pot stocks, and for this he is all in. Do you think they sold there shares on day 3 of trading like the unicorn hunters on wall street? H3ll no! This is a risk I am willing to take. $0.50-0.75/share is not a bad starting point. If you were lucky enough to buy in at IPO levels, your even more ahead of the game. Give it a week or two, let the word spread, and this will run again. Hold your shares, dont be stupid.
Bullboard Posts